Clinical Efficacy and Safety of Fanhdi(®), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study

OBJECTIVE: To evaluate the efficacy and safety of a plasma-derived factor VIII concentrate containing von Willebrand Factor (pdVWF/FVIII) in standard clinical practice in von Willebrand Disease (VWD) patients. METHODS: A retrospective, multicentric, observational study of VWD patients treated with F...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Yuste, Víctor, Alvarez-Román, María Teresa, Palomo Bravo, Ángeles, Galmes, Bernardo J., Nieto Hernández, Maria del Mar, Benítez Hidalgo, Olga, Marzo Alonso, Cristina, Pérez González, Noelia Florencia, Coll, Julia, Núñez, Ramiro, Carrasco, Marina, García Candel, Faustino, Gonzalez-Porras, Jose Ramon, Hernández García, Carmen, Varó Castro, Maria José, Mir, Roser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814963/
https://www.ncbi.nlm.nih.gov/pubmed/35108125
http://dx.doi.org/10.1177/10760296221074348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814963/
https://www.ncbi.nlm.nih.gov/pubmed/35108125
http://dx.doi.org/10.1177/10760296221074348

Ejemplares similares